CompoAtlas

YAMAMOTO NUTRITION - SHURAKHAN

Food supplement declared in France, declaration No 2023-5-1072, decision dated 24 May 2023

YAMAMOTO NUTRITION - SHURAKHAN, from YAMAMOTO S.P.A., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Beta vulgaris 500 mg per day, Sedum roseum 200 mg per day, L-citrulline malate, Bêta-alanine, Chlorhydrate de propionyl L-carnitine. None of the rules we check flags an issue with its declared composition.

Brand
not provided
Food business operator placing the product on the market
YAMAMOTO S.P.A.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Powder
Daily dose
2 cuillères (12 g) par jour
Directions for use
Diluer 12 g (2 cuillères) dans 200 ml d'eau. Prendre une fois par jour. Prendre de préférence avant
Intended populations
Men, Women
Not recommended (according to the manufacturer)
Adolescents (under 18)
Objectives stated by the manufacturer (these are not authorised claims)
Sport
Flavourings
ORANGE

Declaration 243742, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Beta vulgaris L.RacineExtrait sec hydroalcoolique500 mg
Sedum roseum (L.) Scop.RacineMacérât hydroalcoolique200 mg

Other active ingredients

NamePer day
L-citrulline malatenot declared
Bêta-alaninenot declared
Chlorhydrate de propionyl L-carnitinenot declared
L-alanyl-L-glutaminenot declared
Citicolinenot declared
Glutathionnot declared

Additives

E551, E341, E950, E955

Other ingredients

monostearate de glycerol, fructose

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée. Un mode de vie sain et une alimentation variée et équilibrée sont importants. Ne pas laisser à la portée des jeunes enfants. Ne pas utiliser pendant la grossesse et chez l'enfant, ou pendant des périodes prolongées, sans consulter un médecin. Produit destiné aux sportifs adultes. Conserver dans un endroit frais et sec.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Sedum roseum (L.) Scop.
    Read the warning, when it applies and the studies cited

    RHODIOLA - RHODIOLA ROSEA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).

    Sources cited by Health Canada (1)
    • EMA 2024: 20 March 2024 EMA/HMPC/24177/2023 Committee on Herbal Medicinal Products (HMPC) European Union herbal monograph on Rhodiola rosea L., rhizoma et radix Final - Revision 1. Amsterdam (NL): European Medicines Agency, Science Medicines Health. [Accessed 2025 January 21]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-rhodiola-rosea-l-rhizoma-et-radix-revision-1_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, hormone replacement therapy (HRT) or birth control medication (HC 2018; Iovieno et al. 2011; Olsson et al. 2009; Brown et al. 2002).

    Sources cited by Health Canada (4)
    • Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
    • HC 2018: Health Canada. Canada Vigilance Adverse Reaction Online Database. Ottawa (ON): Marketed Health Products Directorate, Health Canada. [Accessed 2025 January 21]. Available from: https://cvp-pcv.hc-sc.gc.ca/arq-rei/index-eng.jsp
    • Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
    • SC 2018: Santé Canada. Base de données en ligne des effets indésirables de Canada Vigilance. Ottawa (ON): Direction des produits de santé commercialisés, Santé Canada. [Consulté le 21 janvier 2025]. Disponible à : https://cvp-pcv.hc-sc.gc.ca/arq-rei/switchlocale.do?lang=fr&url=t.search.recherche

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you have bipolar disorder or bipolar spectrum disorder (Iovieno et al. 2011; Winston and Maimes 2007; Brown et al. 2002).

    Sources cited by Health Canada (3)
    • Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram 2002;56:40-52.
    • Iovieno, N., Dalton, ED., Fava, M., Mischoulon, D. Second-tier natural antidepressants: review and critique. Journal of Affective Disorders 2011;130(3): 343-357.
    • Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester (VT): Healing Arts Press, 2007.

    Known adverse reactions

    Stop use if you experience irritability or insomnia (Pizzorno and Murray 2006; Kelly 2001).

    Sources cited by Health Canada (2)
    • Kelly GS. Rhodiola rosea: A Possible Plant Adaptogen. Alternative Medicine Review 2001;6(3): 293-302. PubMed Review article
    • Pizzorno JE, Murray MT, editors. Textbook of Natural Medicine. 3rd edition, volume 1. St. Louis (MI): Churchill Livingstone Elsevier; 2006.

    Health Canada monograph dated 31 October 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “YAMAMOTO NUTRITION - SHURAKHAN: composition and regulation”, https://compoatlas.com/en/supplements/products/243742-yamamoto-nutrition-shurakhan, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line